Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia

INTRODUCTION: The long-term safety and therapeutic response of sodium oxybate (SXB) in fibromyalgia syndrome (FM) patients were assessed for a combined period of up to 1 year in a prospective, multicenter, open-label, extension study in patients completing 1 of 2 phase 3 randomized, double-blind, co...

詳細記述

保存先:
書誌詳細
主要な著者: Spaeth, Michael, Alegre, Cayetano, Perrot, Serge, Wang, Youyu Grace, Guinta, Diane R, Alvarez-Horine, Sarah, Russell, Irwin Jon
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2013
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978755/
https://ncbi.nlm.nih.gov/pubmed/24286114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4375
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料